M Holdings Securities’s AstraZeneca AZN Stock Holding History

M Holdings Securities’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,423	Closed	-$534K	–	127
2024 Q2	$534K	Buy	+3,423	New	+$515K	0.07%	152
2024 Q1	–	Sell	-5,770	Closed	-$777K	–	131
2023 Q4	$777K	Sell	5,770 -29	-0.5%	-$3.77K	0.09%	131
2023 Q3	$785K	Buy	+5,799	New	+$792K	0.1%	133
2023 Q1	–	Sell	-5,581	Closed	-$751K	–	476
2022 Q4	$757K	Hold	5,581	–	–	0.08%	189
2022 Q3	$612K	Sell	5,581 -49	-0.9%	-$6.22K	0.07%	205
2022 Q2	$744K	Buy	5,630 +1,193	+27%	+$157K	0.08%	184
2022 Q1	$589K	Buy	+4,437	New	+$532K	0.04%	265
2021 Q2	–	Sell	-2,107	Closed	-$210K	–	257
2021 Q1	$210K	Buy	+2,107	New	+$212K	0.02%	460

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

M Holdings Securities's AZN Position: Q3 2024 in Review

M Holdings Securities sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 3,423 shares — an estimated $534K sold.

M Holdings Securities first reported a position in AZN in Q1 2021 and held it in 8 quarters. The position peaked at $785K in Q3 2023. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

M Holdings Securities reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
M Holdings Securities sold 3,423 AstraZeneca shares in Q3 2024, an estimated $534K.
M Holdings Securities first reported a position in AstraZeneca in Q1 2021 and held it in 8 quarters.
M Holdings Securities's AstraZeneca position peaked at $785K in Q3 2023.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on M Holdings Securities's 13F filing for Q3 2024, filed 12 Nov 2024.